Rhythm Biosciences Ltd (RHY)

Sydney
1.260
+0.055(+4.56%)
  • Volume:
    72,374
  • Bid/Ask:
    1.250/1.265
  • Day's Range:
    1.225 - 1.260

RHY Overview

Prev. Close
1.205
Day's Range
1.225-1.26
Revenue
20K
Open
1.225
52 wk Range
1.03-2.08
EPS
-0.042
Volume
72,374
Market Cap
273.03M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
118,538
P/E Ratio
-32.22
Beta
3.47
1-Year Change
-1.95%
Shares Outstanding
216,692,394
Next Earnings Date
-
What is your sentiment on Rhythm Biosciences?
or
Vote to see community's results!

Rhythm Biosciences Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Rhythm Biosciences Ltd Analysis

Rhythm Biosciences Ltd Company Profile

Rhythm Biosciences Ltd Company Profile

Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralNeutral
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral